Interviews with Medtech Startup CEOs

Greg Walters, CEO of Excision Medical, on developing RF-enabled leaflet modification technology for TAVR — and his approach to prototyping, first-in-human risk, and what acquirers actually look for in pre-revenue medtech.

Jaeson Bang, Founder & CEO of Future Cardia, shares how developing a subcutaneous heart-failure monitoring platform came from challenging assumptions — and why delaying VC capital can preserve leverage and speed.

Urologist-turned-founder Dr. Adam Kadlec shares how he built Rivermark and FloStent — a reversible, workflow-friendly device for BPH — by designing for real practice patterns and uncovering what drives trial enrollment.

Andrew Holman, MD, spent a decade building the immuno-autonomics concept before launching Inmedix's CloudHRV — a diagnostic that measures biological stress as a vital sign. His approach offers lessons in creating demand first.

May Health CEO Colby Holtshouse is tackling PCOS and infertility with a minimally invasive ovarian ablation device. She explains why staged evidence — built in layers rather than a massive trial — is the fastest path to early commercial traction.

Reia CEO Kaitlin Maier turned a student project into the first self-managed pessary that treats all stages of pelvic organ prolapse — proving that limited resources can sharpen design, focus, and innovation.